Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaposiform Hemangioendothelioma (KHE)”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)UnknownNCT04409691
What this trial is testing

SCMC Trial on KHE With KMP (V.2020)

Who this might be right for
Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
Shanghai Children's Medical Center 20
Not applicableLooking for participantsNCT03001180
What this trial is testing

Identification of Biomarkers for Patients with Vascular Anomalies

Who this might be right for
Vascular AnomalyGeneralized Lymphatic AnomalyKaposiform Hemangioendothelioma+4 more
Children's Hospital Medical Center, Cincinnati 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02110069
What this trial is testing

Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Who this might be right for
Kaposiform Hemangioendothelioma (KHE)Kasabach-Merritt SyndromeTufted Angioma
Boston Children's Hospital 4